Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Stocks To Watch: ACAD, ITI, MAXR, NKTR, OSTK, SIEN

Published 09/11/2019, 02:13 AM
Updated 07/09/2023, 06:31 AM

ACADIA Pharmaceuticals

ACAD made a monster move on Monday on good news and then pulled back. On Tuesday, it was up 2.37, or 6%, to 41.22, on 7.4 million shares. I think it’s going to go higher. I’m looking for 50-51.

Iteris

ITI has a beautiful inverse head-and-shoulders, a base, a breakout, a retest, consolidate, and go. It’s four waves up and I think the fifth one has started. It was up 26 cents, or 5%, to 5.69, or 236,025 shares traded on Tuesday. I think it will go to 6 1/2, 7 1/4, and 8.

Maxar Technologies

MAXR had a swing put on it that didn’t work, it came down and retest for six more weeks, and then popped out on Tuesday. It was a big day, jumping 1.35, or 19.2%, to 8.38, on 5.4 million shares. Look for it to test 10. The top of the channel may be tested as well at about 12 and maybe 12 3/4.

Nektar Therapeutics

NKTR which I love the chart and the company, popped 2.05, or 11 1/2%, to 19.91, on 4.3 million shares on Tuesday. It’s at the bottom of the long-term channel, but it’s telling me that it may have a big move coming up. Halfway into the gap is 24, and then 28 are the targets.

Overstock.com

OSTK is doing well on a big comeback. It’s been up five days in a row, and on Tuesday, it popped another 1.85, or 9.5%, to 21.32, on 5.7 million shares. The volume was the best in two weeks. I think it’s immediately going to test the zone in the 22 3/4-23 1/2 area. If it gets through that, I expect it to get to 26-27.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Sientra

SIEN looks like it’s ready for a reversal day, perhaps. On Tuesday, it advanced 46 cents, or 7%, to 7.08, on 1 million shares. If this can get through 7.33-.35, then 8 1/2 and 10 are the targets.

Stocks on the long side

ACADIA Pharmaceuticals Inc. (ACAD), Akebia Therapeutics, Inc. (AKBA), AMAG Pharmaceuticals, Inc. (AMAG), Endo International plc (ENDP), Francesca's Holdings Corporation (FRAN), G1 Therapeutics, Inc. (GTHX), At Home Group Inc. (HOME), Iteris, Inc. (ITI), LSB Industries, Inc. (LXU), Maxar Technologies Inc. (MAXR), Mesoblast Limited (MESO), The Michaels Companies, Inc. (MIK), Mallinckrodt (NYSE:MNK) Public Limited Company (MNK), Nektar Therapeutics (NKTR), Owens & Minor, Inc. (OMI), Orion Group Holdings, Inc. (ORN), Overstock.com , Inc. (NASDAQ:OSTK), Puma Biotechnology, Inc. (PBYI), Pier 1 Imports, Inc. (PIR), Pieris Pharmaceuticals, Inc. (PIRS), Sientra, Inc. (SIEN), and Tenneco Inc. (TEN).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.